Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001655759-23-000041
Filing Date
2023-05-05
Accepted
2023-05-05 08:58:24
Documents
73
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q arvn-20230331.htm   iXBRL 10-Q 1016779
2 EX-31.1 arvn-20230331x10qex311.htm EX-31.1 10389
3 EX-31.2 arvn-20230331x10qex312.htm EX-31.2 10553
4 EX-32.1 arvn-20230331x10qex321.htm EX-32.1 5117
5 EX-32.2 arvn-20230331x10qex322.htm EX-32.2 4947
  Complete submission text file 0001655759-23-000041.txt   5867171

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT arvn-20230331.xsd EX-101.SCH 49942
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT arvn-20230331_cal.xml EX-101.CAL 60082
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT arvn-20230331_def.xml EX-101.DEF 204414
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT arvn-20230331_lab.xml EX-101.LAB 571437
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT arvn-20230331_pre.xml EX-101.PRE 363843
67 EXTRACTED XBRL INSTANCE DOCUMENT arvn-20230331_htm.xml XML 884674
Mailing Address 395 WINCHESTER AVE 5 SCIENCE PARK NEW HAVEN CT 06511
Business Address 395 WINCHESTER AVE 5 SCIENCE PARK NEW HAVEN CT 06511 203-535-1456
ARVINAS, INC. (Filer) CIK: 0001655759 (see all company filings)

EIN.: 472566120 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38672 | Film No.: 23891483
SIC: 2834 Pharmaceutical Preparations